Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Forced Transdifferentiation01:28

Forced Transdifferentiation

2.5K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.5K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Large-scale profiling of blood microbial signatures in patients with Parkinson's disease and its association with disease progression: a cross-sectional study" [EBioMedicine 126(2026) 106224].

EBioMedicine·2026
Same author

Haplotype-resolved methylomes reveal parent-of-origin DNA methylation imbalance in autism spectrum disorder.

Science advances·2026
Same author

Multiomic analyses delineate human neuroendocrine tumor cell states in relation to normal enteroendocrine cell ontogeny.

The Journal of clinical investigation·2026
Same author

An extra virgin olive oil diet impairs glycemic control, but mitigates high-fat diet-induced inflammation compared to coconut oil in mice.

Frontiers in nutrition·2026
Same author

Mechanism of CRM1 Inhibition by Lansoprazole and Its Synergy with Cisplatin in Gastric Cancer.

Journal of medicinal chemistry·2026
Same author

Diabetes mellitus complications and their association with patient-reported outcome measures: a longitudinal study of the SwissDiab cohort.

Diabetes research and clinical practice·2026

Related Experiment Video

Updated: Mar 23, 2026

In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas
09:31

In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas

Published on: June 10, 2016

9.9K

Direct Reprogramming for Pancreatic Beta-Cells Using Key Developmental Genes.

Claudia Cavelti-Weder1, Weida Li2, Adrian Zumsteg2

  • 1Section on Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.

Current Pathobiology Reports
|March 22, 2016
PubMed
Summary

Direct reprogramming converts cells to insulin-producing beta-cells for diabetes treatment. This review covers advances and challenges in creating functional, long-lasting beta-cells via cell reprogramming.

Keywords:
Beta-cellsCell fate conversionDevelopmental regulatorsDirect reprogramming

More Related Videos

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors
09:23

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors

Published on: March 7, 2017

8.4K
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

3.3K

Related Experiment Videos

Last Updated: Mar 23, 2026

In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas
09:31

In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas

Published on: June 10, 2016

9.9K
Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors
09:23

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors

Published on: March 7, 2017

8.4K
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

3.3K

Area of Science:

  • Regenerative Medicine
  • Cell Biology
  • Endocrinology

Background:

  • Direct reprogramming offers a novel pathway in regenerative medicine, bypassing pluripotent stages.
  • Generating functional insulin-secreting cells is crucial for diabetes cell therapy.
  • Existing therapies face limitations due to insufficient endogenous beta-cells.

Purpose of the Study:

  • To review recent advancements in direct beta-cell reprogramming.
  • To discuss strategies for generating functional insulin-producing cells.
  • To highlight challenges in achieving long-lasting therapeutic effects.

Main Methods:

  • Introduction of key regulatory factors to induce cell conversion.
  • Focus on reprogramming non-beta-cells into insulin-secreting cells.
  • Review of current literature on beta-cell reprogramming techniques.

Main Results:

  • Significant progress has been made in converting various cell types into insulin-positive cells.
  • Identification of critical regulators for beta-cell development and function.
  • Demonstration of potential therapeutic applications for type 1 diabetes.

Conclusions:

  • Direct reprogramming is a promising strategy for diabetes regenerative medicine.
  • Further research is needed to overcome challenges in creating stable, functional beta-cells.
  • Optimizing reprogramming protocols is key for clinical translation.